> top > projects > spacy-test > docs > PubMed:3921191 > annotations
spacy-test Home  

PubMed:3921191 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-6 NN denotes 6-OHDA
spaCy_T1 7-14 NNS denotes lesions
spaCy_T2 15-17 IN denotes of
spaCy_T3 18-21 DT denotes the
spaCy_T4 22-29 JJ denotes ventral
spaCy_T5 30-39 JJ denotes tegmental
spaCy_T6 40-44 NN denotes area
spaCy_T7 45-50 NN denotes block
spaCy_T8 51-67 JJ denotes morphine-induced
spaCy_T9 68-71 CC denotes but
spaCy_T10 72-75 RB denotes not
spaCy_T11 76-95 JJ denotes amphetamine-induced
spaCy_T12 96-108 NN denotes facilitation
spaCy_T13 109-111 IN denotes of
spaCy_T14 112-128 NN denotes self-stimulation
spaCy_T15 128-129 . denotes .
spaCy_T16 130-133 DT denotes The
spaCy_T17 134-142 JJ denotes biphasic
spaCy_T18 143-149 NN denotes effect
spaCy_T19 150-152 IN denotes of
spaCy_T20 153-161 NN denotes morphine
spaCy_T21 162-164 IN denotes on
spaCy_T22 165-177 JJ denotes intracranial
spaCy_T23 178-194 NN denotes self-stimulation
spaCy_T24 195-196 -LRB- denotes (
spaCy_T25 196-200 NNP denotes ICSS
spaCy_T26 200-201 -RRB- denotes )
spaCy_T27 202-203 -LRB- denotes (
spaCy_T28 203-214 NN denotes suppression
spaCy_T29 215-223 VBN denotes followed
spaCy_T30 224-226 IN denotes by
spaCy_T31 227-239 NN denotes facilitation
spaCy_T32 239-240 -RRB- denotes )
spaCy_T33 241-244 VBD denotes was
spaCy_T34 245-253 VBN denotes examined
spaCy_T35 254-256 IN denotes in
spaCy_T36 257-261 NNS denotes rats
spaCy_T37 262-271 VBG denotes following
spaCy_T38 272-282 NNS denotes injections
spaCy_T39 283-285 IN denotes of
spaCy_T40 286-292 NN denotes 6-OHDA
spaCy_T41 293-295 CC denotes or
spaCy_T42 296-303 NN denotes vehicle
spaCy_T43 304-308 IN denotes into
spaCy_T44 309-312 DT denotes the
spaCy_T45 313-320 JJ denotes ventral
spaCy_T46 321-330 JJ denotes tegmental
spaCy_T47 331-335 NN denotes area
spaCy_T48 336-337 -LRB- denotes (
spaCy_T49 337-340 NNP denotes VTA
spaCy_T50 340-341 -RRB- denotes )
spaCy_T51 341-342 . denotes .
spaCy_T52 343-349 IN denotes During
spaCy_T53 350-351 CD denotes 7
spaCy_T54 352-356 NNS denotes days
spaCy_T55 357-359 IN denotes of
spaCy_T56 360-367 JJ denotes chronic
spaCy_T57 368-382 NN denotes administration
spaCy_T58 383-385 IN denotes of
spaCy_T59 386-394 NN denotes morphine
spaCy_T60 394-395 , denotes ,
spaCy_T61 396-409 JJ denotes sham-lesioned
spaCy_T62 410-417 NNS denotes animals
spaCy_T63 418-427 RB denotes gradually
spaCy_T64 428-437 VBD denotes developed
spaCy_T65 438-447 NN denotes tolerance
spaCy_T66 448-450 TO denotes to
spaCy_T67 451-454 DT denotes the
spaCy_T68 455-468 JJ denotes rate-reducing
spaCy_T69 469-476 NNS denotes effects
spaCy_T70 477-479 IN denotes of
spaCy_T71 480-483 DT denotes the
spaCy_T72 484-488 NN denotes drug
spaCy_T73 489-492 CC denotes and
spaCy_T74 493-494 DT denotes a
spaCy_T75 495-505 JJ denotes concurrent
spaCy_T76 506-519 NN denotes sensitization
spaCy_T77 520-522 TO denotes to
spaCy_T78 523-526 PRP$ denotes its
spaCy_T79 527-541 JJ denotes rate-enhancing
spaCy_T80 542-549 NNS denotes effects
spaCy_T81 550-551 -LRB- denotes (
spaCy_T82 551-559 VBN denotes measured
spaCy_T83 560-561 CD denotes 1
spaCy_T84 562-565 CC denotes and
spaCy_T85 566-567 CD denotes 3
spaCy_T86 568-569 JJ denotes h
spaCy_T87 570-584 NN denotes post-injection
spaCy_T88 584-585 , denotes ,
spaCy_T89 586-598 RB denotes respectively
spaCy_T90 598-599 -RRB- denotes )
spaCy_T91 599-600 . denotes .
spaCy_T92 601-604 NNP denotes VTA
spaCy_T93 605-613 VBD denotes lesioned
spaCy_T94 614-618 NNS denotes rats
spaCy_T95 619-625 VBD denotes showed
spaCy_T96 626-633 DT denotes neither
spaCy_T97 634-643 NN denotes tolerance
spaCy_T98 644-646 TO denotes to
spaCy_T99 647-650 DT denotes the
spaCy_T100 651-655 NN denotes rate
spaCy_T101 656-667 NN denotes suppression
spaCy_T102 668-671 CC denotes nor
spaCy_T103 672-675 DT denotes any
spaCy_T104 676-688 NN denotes facilitation
spaCy_T105 689-691 IN denotes of
spaCy_T106 692-696 NNP denotes ICSS
spaCy_T107 697-707 IN denotes throughout
spaCy_T108 708-715 NN denotes testing
spaCy_T109 715-716 . denotes .
spaCy_T110 717-728 NNP denotes Amphetamine
spaCy_T111 728-730 POS denotes 's
spaCy_T112 731-743 NN denotes facilitation
spaCy_T113 744-746 IN denotes of
spaCy_T114 747-751 NNP denotes ICSS
spaCy_T115 752-760 VBD denotes remained
spaCy_T116 761-767 JJ denotes intact
spaCy_T117 768-770 IN denotes in
spaCy_T118 771-774 DT denotes all
spaCy_T119 775-783 NNS denotes subjects
spaCy_T120 783-784 . denotes .
spaCy_T121 785-788 DT denotes The
spaCy_T122 789-795 NN denotes lesion
spaCy_T123 796-799 VBD denotes was
spaCy_T124 800-810 VBN denotes restricted
spaCy_T125 811-813 TO denotes to
spaCy_T126 814-817 DT denotes the
spaCy_T127 818-821 NNP denotes VTA
spaCy_T128 822-826 NN denotes cell
spaCy_T129 827-833 NNS denotes bodies
spaCy_T130 834-837 CC denotes but
spaCy_T131 838-846 VBD denotes produced
spaCy_T132 847-848 DT denotes a
spaCy_T133 849-860 JJ denotes significant
spaCy_T134 861-870 NN denotes depletion
spaCy_T135 871-873 IN denotes of
spaCy_T136 874-882 NN denotes dopamine
spaCy_T137 883-884 -LRB- denotes (
spaCy_T138 884-886 NNP denotes DA
spaCy_T139 886-887 -RRB- denotes )
spaCy_T140 888-890 IN denotes in
spaCy_T141 891-895 DT denotes both
spaCy_T142 896-899 DT denotes the
spaCy_T143 900-907 NN denotes nucleus
spaCy_T144 908-917 VBZ denotes accumbens
spaCy_T145 918-921 CC denotes and
spaCy_T146 922-924 IN denotes in
spaCy_T147 925-928 DT denotes the
spaCy_T148 929-937 NN denotes striatum
spaCy_T149 937-938 . denotes .
spaCy_T150 939-947 NNP denotes Morphine
spaCy_T151 948-960 NN denotes facilitation
spaCy_T152 961-963 IN denotes of
spaCy_T153 964-968 NNP denotes ICSS
spaCy_T154 969-971 VBZ denotes is
spaCy_T155 972-981 VBN denotes suggested
spaCy_T156 982-984 TO denotes to
spaCy_T157 985-987 VB denotes be
spaCy_T158 988-997 JJ denotes dependent
spaCy_T159 998-1000 IN denotes on
spaCy_T160 1001-1003 DT denotes an
spaCy_T161 1004-1012 JJ denotes indirect
spaCy_T162 1013-1019 NN denotes opiate
spaCy_T163 1020-1032 NNP denotes receptor-VTA
spaCy_T164 1033-1035 NNP denotes DA
spaCy_T165 1036-1040 NN denotes cell
spaCy_T166 1041-1052 NN denotes interaction
spaCy_T167 1052-1053 . denotes .
spaCy_T168 1054-1056 PRP denotes It
spaCy_T169 1057-1059 VBZ denotes is
spaCy_T170 1060-1064 RB denotes also
spaCy_T171 1065-1073 VBN denotes proposed
spaCy_T172 1074-1078 IN denotes that
spaCy_T173 1079-1090 JJ denotes amphetamine
spaCy_T174 1091-1103 NN denotes facilitation
spaCy_T175 1104-1106 IN denotes of
spaCy_T176 1107-1111 NNP denotes ICSS
spaCy_T177 1112-1114 VBZ denotes is
spaCy_T178 1115-1116 DT denotes a
spaCy_T179 1117-1118 `` denotes '
spaCy_T180 1118-1122 NN denotes mass
spaCy_T181 1123-1129 NN denotes action
spaCy_T182 1129-1130 '' denotes '
spaCy_T183 1131-1137 NN denotes effect
spaCy_T184 1138-1147 VBG denotes involving
spaCy_T185 1148-1151 DT denotes the
spaCy_T186 1152-1156 JJ denotes full
spaCy_T187 1157-1159 NNP denotes DA
spaCy_T188 1160-1168 NN denotes terminal
spaCy_T189 1169-1173 NN denotes area
spaCy_T190 1174-1176 IN denotes of
spaCy_T191 1177-1180 DT denotes the
spaCy_T192 1181-1190 NN denotes forebrain
spaCy_T193 1191-1197 RB denotes rather
spaCy_T194 1198-1202 IN denotes than
spaCy_T195 1203-1204 DT denotes a
spaCy_T196 1205-1214 NN denotes subregion
spaCy_T197 1215-1217 IN denotes of
spaCy_T198 1218-1222 DT denotes that
spaCy_T199 1223-1227 NN denotes area
spaCy_T200 1227-1228 . denotes .
spaCy_R0 spaCy_T0 spaCy_T1 compound 6-OHDA,lesions
spaCy_R1 spaCy_T1 spaCy_T1 ROOT lesions,lesions
spaCy_R10 spaCy_T10 spaCy_T11 neg not,amphetamine-induced
spaCy_R100 spaCy_T100 spaCy_T101 compound rate,suppression
spaCy_R101 spaCy_T101 spaCy_T98 pobj suppression,to
spaCy_R102 spaCy_T102 spaCy_T101 cc nor,suppression
spaCy_R103 spaCy_T103 spaCy_T104 det any,facilitation
spaCy_R104 spaCy_T104 spaCy_T101 conj facilitation,suppression
spaCy_R105 spaCy_T105 spaCy_T104 prep of,facilitation
spaCy_R106 spaCy_T106 spaCy_T105 pobj ICSS,of
spaCy_R107 spaCy_T107 spaCy_T104 prep throughout,facilitation
spaCy_R108 spaCy_T108 spaCy_T107 pobj testing,throughout
spaCy_R109 spaCy_T109 spaCy_T95 punct .,showed
spaCy_R11 spaCy_T11 spaCy_T8 conj amphetamine-induced,morphine-induced
spaCy_R110 spaCy_T110 spaCy_T112 poss Amphetamine,facilitation
spaCy_R111 spaCy_T111 spaCy_T110 case 's,Amphetamine
spaCy_R112 spaCy_T112 spaCy_T115 nsubj facilitation,remained
spaCy_R113 spaCy_T113 spaCy_T112 prep of,facilitation
spaCy_R114 spaCy_T114 spaCy_T113 pobj ICSS,of
spaCy_R115 spaCy_T115 spaCy_T115 ROOT remained,remained
spaCy_R116 spaCy_T116 spaCy_T115 acomp intact,remained
spaCy_R117 spaCy_T117 spaCy_T116 prep in,intact
spaCy_R118 spaCy_T118 spaCy_T119 det all,subjects
spaCy_R119 spaCy_T119 spaCy_T117 pobj subjects,in
spaCy_R12 spaCy_T12 spaCy_T8 conj facilitation,morphine-induced
spaCy_R120 spaCy_T120 spaCy_T115 punct .,remained
spaCy_R121 spaCy_T121 spaCy_T122 det The,lesion
spaCy_R122 spaCy_T122 spaCy_T124 nsubjpass lesion,restricted
spaCy_R123 spaCy_T123 spaCy_T124 auxpass was,restricted
spaCy_R124 spaCy_T124 spaCy_T124 ROOT restricted,restricted
spaCy_R125 spaCy_T125 spaCy_T124 prep to,restricted
spaCy_R126 spaCy_T126 spaCy_T129 det the,bodies
spaCy_R127 spaCy_T127 spaCy_T129 compound VTA,bodies
spaCy_R128 spaCy_T128 spaCy_T129 compound cell,bodies
spaCy_R129 spaCy_T129 spaCy_T125 pobj bodies,to
spaCy_R13 spaCy_T13 spaCy_T12 prep of,facilitation
spaCy_R130 spaCy_T130 spaCy_T124 cc but,restricted
spaCy_R131 spaCy_T131 spaCy_T124 conj produced,restricted
spaCy_R132 spaCy_T132 spaCy_T134 det a,depletion
spaCy_R133 spaCy_T133 spaCy_T134 amod significant,depletion
spaCy_R134 spaCy_T134 spaCy_T131 dobj depletion,produced
spaCy_R135 spaCy_T135 spaCy_T134 prep of,depletion
spaCy_R136 spaCy_T136 spaCy_T135 pobj dopamine,of
spaCy_R137 spaCy_T137 spaCy_T138 punct (,DA
spaCy_R138 spaCy_T138 spaCy_T134 appos DA,depletion
spaCy_R139 spaCy_T139 spaCy_T134 punct ),depletion
spaCy_R14 spaCy_T14 spaCy_T13 pobj self-stimulation,of
spaCy_R140 spaCy_T140 spaCy_T131 prep in,produced
spaCy_R141 spaCy_T141 spaCy_T144 det both,accumbens
spaCy_R142 spaCy_T142 spaCy_T143 det the,nucleus
spaCy_R143 spaCy_T143 spaCy_T144 compound nucleus,accumbens
spaCy_R144 spaCy_T144 spaCy_T140 pobj accumbens,in
spaCy_R145 spaCy_T145 spaCy_T144 cc and,accumbens
spaCy_R146 spaCy_T146 spaCy_T131 prep in,produced
spaCy_R147 spaCy_T147 spaCy_T148 det the,striatum
spaCy_R148 spaCy_T148 spaCy_T146 pobj striatum,in
spaCy_R149 spaCy_T149 spaCy_T124 punct .,restricted
spaCy_R15 spaCy_T15 spaCy_T1 punct .,lesions
spaCy_R150 spaCy_T150 spaCy_T151 compound Morphine,facilitation
spaCy_R151 spaCy_T151 spaCy_T155 nsubjpass facilitation,suggested
spaCy_R152 spaCy_T152 spaCy_T151 prep of,facilitation
spaCy_R153 spaCy_T153 spaCy_T152 pobj ICSS,of
spaCy_R154 spaCy_T154 spaCy_T155 auxpass is,suggested
spaCy_R155 spaCy_T155 spaCy_T155 ROOT suggested,suggested
spaCy_R156 spaCy_T156 spaCy_T157 aux to,be
spaCy_R157 spaCy_T157 spaCy_T155 xcomp be,suggested
spaCy_R158 spaCy_T158 spaCy_T157 acomp dependent,be
spaCy_R159 spaCy_T159 spaCy_T158 prep on,dependent
spaCy_R16 spaCy_T16 spaCy_T18 det The,effect
spaCy_R160 spaCy_T160 spaCy_T162 det an,opiate
spaCy_R161 spaCy_T161 spaCy_T162 amod indirect,opiate
spaCy_R162 spaCy_T162 spaCy_T166 compound opiate,interaction
spaCy_R163 spaCy_T163 spaCy_T166 compound receptor-VTA,interaction
spaCy_R164 spaCy_T164 spaCy_T166 compound DA,interaction
spaCy_R165 spaCy_T165 spaCy_T166 compound cell,interaction
spaCy_R166 spaCy_T166 spaCy_T159 pobj interaction,on
spaCy_R167 spaCy_T167 spaCy_T155 punct .,suggested
spaCy_R168 spaCy_T168 spaCy_T171 nsubjpass It,proposed
spaCy_R169 spaCy_T169 spaCy_T171 auxpass is,proposed
spaCy_R17 spaCy_T17 spaCy_T18 amod biphasic,effect
spaCy_R170 spaCy_T170 spaCy_T171 advmod also,proposed
spaCy_R171 spaCy_T171 spaCy_T171 ROOT proposed,proposed
spaCy_R172 spaCy_T172 spaCy_T177 mark that,is
spaCy_R173 spaCy_T173 spaCy_T174 compound amphetamine,facilitation
spaCy_R174 spaCy_T174 spaCy_T177 nsubj facilitation,is
spaCy_R175 spaCy_T175 spaCy_T174 prep of,facilitation
spaCy_R176 spaCy_T176 spaCy_T175 pobj ICSS,of
spaCy_R177 spaCy_T177 spaCy_T171 ccomp is,proposed
spaCy_R178 spaCy_T178 spaCy_T183 det a,effect
spaCy_R179 spaCy_T179 spaCy_T183 punct ',effect
spaCy_R18 spaCy_T18 spaCy_T18 ROOT effect,effect
spaCy_R180 spaCy_T180 spaCy_T181 amod mass,action
spaCy_R181 spaCy_T181 spaCy_T183 nmod action,effect
spaCy_R182 spaCy_T182 spaCy_T183 punct ',effect
spaCy_R183 spaCy_T183 spaCy_T177 attr effect,is
spaCy_R184 spaCy_T184 spaCy_T183 acl involving,effect
spaCy_R185 spaCy_T185 spaCy_T189 det the,area
spaCy_R186 spaCy_T186 spaCy_T189 amod full,area
spaCy_R187 spaCy_T187 spaCy_T189 compound DA,area
spaCy_R188 spaCy_T188 spaCy_T189 compound terminal,area
spaCy_R189 spaCy_T189 spaCy_T184 dobj area,involving
spaCy_R19 spaCy_T19 spaCy_T18 prep of,effect
spaCy_R190 spaCy_T190 spaCy_T189 prep of,area
spaCy_R191 spaCy_T191 spaCy_T192 det the,forebrain
spaCy_R192 spaCy_T192 spaCy_T190 pobj forebrain,of
spaCy_R193 spaCy_T193 spaCy_T194 advmod rather,than
spaCy_R194 spaCy_T194 spaCy_T189 cc than,area
spaCy_R195 spaCy_T195 spaCy_T196 det a,subregion
spaCy_R196 spaCy_T196 spaCy_T189 conj subregion,area
spaCy_R197 spaCy_T197 spaCy_T196 prep of,subregion
spaCy_R198 spaCy_T198 spaCy_T199 det that,area
spaCy_R199 spaCy_T199 spaCy_T197 pobj area,of
spaCy_R2 spaCy_T2 spaCy_T1 prep of,lesions
spaCy_R20 spaCy_T20 spaCy_T19 pobj morphine,of
spaCy_R200 spaCy_T200 spaCy_T171 punct .,proposed
spaCy_R21 spaCy_T21 spaCy_T18 prep on,effect
spaCy_R22 spaCy_T22 spaCy_T23 amod intracranial,self-stimulation
spaCy_R23 spaCy_T23 spaCy_T21 pobj self-stimulation,on
spaCy_R24 spaCy_T24 spaCy_T25 punct (,ICSS
spaCy_R25 spaCy_T25 spaCy_T23 appos ICSS,self-stimulation
spaCy_R26 spaCy_T26 spaCy_T25 punct ),ICSS
spaCy_R27 spaCy_T27 spaCy_T34 punct (,examined
spaCy_R28 spaCy_T28 spaCy_T34 nsubjpass suppression,examined
spaCy_R29 spaCy_T29 spaCy_T28 acl followed,suppression
spaCy_R3 spaCy_T3 spaCy_T7 det the,block
spaCy_R30 spaCy_T30 spaCy_T29 agent by,followed
spaCy_R31 spaCy_T31 spaCy_T30 pobj facilitation,by
spaCy_R32 spaCy_T32 spaCy_T28 punct ),suppression
spaCy_R33 spaCy_T33 spaCy_T34 auxpass was,examined
spaCy_R34 spaCy_T34 spaCy_T18 parataxis examined,effect
spaCy_R35 spaCy_T35 spaCy_T34 prep in,examined
spaCy_R36 spaCy_T36 spaCy_T35 pobj rats,in
spaCy_R37 spaCy_T37 spaCy_T36 acl following,rats
spaCy_R38 spaCy_T38 spaCy_T37 dobj injections,following
spaCy_R39 spaCy_T39 spaCy_T38 prep of,injections
spaCy_R4 spaCy_T4 spaCy_T7 nmod ventral,block
spaCy_R40 spaCy_T40 spaCy_T39 pobj 6-OHDA,of
spaCy_R41 spaCy_T41 spaCy_T40 cc or,6-OHDA
spaCy_R42 spaCy_T42 spaCy_T40 conj vehicle,6-OHDA
spaCy_R43 spaCy_T43 spaCy_T37 prep into,following
spaCy_R44 spaCy_T44 spaCy_T47 det the,area
spaCy_R45 spaCy_T45 spaCy_T47 amod ventral,area
spaCy_R46 spaCy_T46 spaCy_T47 amod tegmental,area
spaCy_R47 spaCy_T47 spaCy_T43 pobj area,into
spaCy_R48 spaCy_T48 spaCy_T47 punct (,area
spaCy_R49 spaCy_T49 spaCy_T47 appos VTA,area
spaCy_R5 spaCy_T5 spaCy_T7 amod tegmental,block
spaCy_R50 spaCy_T50 spaCy_T47 punct ),area
spaCy_R51 spaCy_T51 spaCy_T34 punct .,examined
spaCy_R52 spaCy_T52 spaCy_T64 prep During,developed
spaCy_R53 spaCy_T53 spaCy_T54 nummod 7,days
spaCy_R54 spaCy_T54 spaCy_T52 pobj days,During
spaCy_R55 spaCy_T55 spaCy_T54 prep of,days
spaCy_R56 spaCy_T56 spaCy_T57 amod chronic,administration
spaCy_R57 spaCy_T57 spaCy_T55 pobj administration,of
spaCy_R58 spaCy_T58 spaCy_T57 prep of,administration
spaCy_R59 spaCy_T59 spaCy_T58 pobj morphine,of
spaCy_R6 spaCy_T6 spaCy_T7 compound area,block
spaCy_R60 spaCy_T60 spaCy_T64 punct ",",developed
spaCy_R61 spaCy_T61 spaCy_T62 amod sham-lesioned,animals
spaCy_R62 spaCy_T62 spaCy_T64 nsubj animals,developed
spaCy_R63 spaCy_T63 spaCy_T64 advmod gradually,developed
spaCy_R64 spaCy_T64 spaCy_T64 ROOT developed,developed
spaCy_R65 spaCy_T65 spaCy_T64 dobj tolerance,developed
spaCy_R66 spaCy_T66 spaCy_T65 prep to,tolerance
spaCy_R67 spaCy_T67 spaCy_T69 det the,effects
spaCy_R68 spaCy_T68 spaCy_T69 amod rate-reducing,effects
spaCy_R69 spaCy_T69 spaCy_T66 pobj effects,to
spaCy_R7 spaCy_T7 spaCy_T2 pobj block,of
spaCy_R70 spaCy_T70 spaCy_T69 prep of,effects
spaCy_R71 spaCy_T71 spaCy_T72 det the,drug
spaCy_R72 spaCy_T72 spaCy_T70 pobj drug,of
spaCy_R73 spaCy_T73 spaCy_T72 cc and,drug
spaCy_R74 spaCy_T74 spaCy_T76 det a,sensitization
spaCy_R75 spaCy_T75 spaCy_T76 amod concurrent,sensitization
spaCy_R76 spaCy_T76 spaCy_T72 conj sensitization,drug
spaCy_R77 spaCy_T77 spaCy_T76 prep to,sensitization
spaCy_R78 spaCy_T78 spaCy_T80 poss its,effects
spaCy_R79 spaCy_T79 spaCy_T80 amod rate-enhancing,effects
spaCy_R8 spaCy_T8 spaCy_T1 appos morphine-induced,lesions
spaCy_R80 spaCy_T80 spaCy_T77 pobj effects,to
spaCy_R81 spaCy_T81 spaCy_T80 punct (,effects
spaCy_R82 spaCy_T82 spaCy_T80 acl measured,effects
spaCy_R83 spaCy_T83 spaCy_T87 nummod 1,post-injection
spaCy_R84 spaCy_T84 spaCy_T83 cc and,1
spaCy_R85 spaCy_T85 spaCy_T83 conj 3,1
spaCy_R86 spaCy_T86 spaCy_T87 compound h,post-injection
spaCy_R87 spaCy_T87 spaCy_T82 dobj post-injection,measured
spaCy_R88 spaCy_T88 spaCy_T87 punct ",",post-injection
spaCy_R89 spaCy_T89 spaCy_T82 advmod respectively,measured
spaCy_R9 spaCy_T9 spaCy_T8 cc but,morphine-induced
spaCy_R90 spaCy_T90 spaCy_T80 punct ),effects
spaCy_R91 spaCy_T91 spaCy_T64 punct .,developed
spaCy_R92 spaCy_T92 spaCy_T94 amod VTA,rats
spaCy_R93 spaCy_T93 spaCy_T94 amod lesioned,rats
spaCy_R94 spaCy_T94 spaCy_T95 nsubj rats,showed
spaCy_R95 spaCy_T95 spaCy_T95 ROOT showed,showed
spaCy_R96 spaCy_T96 spaCy_T97 det neither,tolerance
spaCy_R97 spaCy_T97 spaCy_T95 dobj tolerance,showed
spaCy_R98 spaCy_T98 spaCy_T95 dative to,showed
spaCy_R99 spaCy_T99 spaCy_T101 det the,suppression